Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: Timing is important for maximizing clearance

American Journal of Kidney Diseases

Volumn 36, Issue 1, 2000, Pages 177-183

  Zdunek, M ^a   Mitra, A ^a   Mokrzycki, M H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Digibind; Digoxin toxicity; Digoxin specific antibody fragments (Fabs); Plasma exchange (PE); Plasmapheresis; Renal failure

Indexed keywords

DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG INTOXICATION; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; MALE; PLASMAPHERESIS; TREATMENT OUTCOME;

EID: 0033932352     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.8291     Document Type: Article

References (34)

1. G Ordog S Benaron V Bhasin J Wasserberger S Balasubramanium Serum digoxin level and mortality in 5,100 patients Ann Emerg Med 16 1987 32 39
2. TW Smith EM Antman PL Friedman CM Blatt JD Marsh Digitalis glycosides: Mechanisms and manifestations of toxicity. Part III Prog Cardiovasc Dis 27 1984 21 56
3. E Antman T Wenger V Butler E Haber T Smith Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments Circulation 81 1990 1744 1752
4. M Ujhelyi S Robert Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity Clin Pharmacokinet 28 1995 483 493
5. MR Ujhelyi S Robert DM Cummings RD Colucci PJ Green J Sailstad PH Vlasses BJ Zarowitz Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin Ann Intern Med 119 1993 273 277
6. NM Allen GD Dunham JM Sailstad JW Findlay Clinical and pharmacokinetic profiles of digoxin immune-Fab in four patients with renal impairment Drug Intelligence in Clinical Pharmacology, Ann Pharmacother 25 1991 1315 1320
7. TL Wenger Clinical experience with digoxin immune Fab (ovine) Prim Cardiol 1 1988 5 11
8. GM Rabetoy CA Price JWA Findlay JM Sailstad Treatment of digoxin intoxication in a renal failure patient with digoxin-specific antibody fragments and plasmapheresis Am J Nephrol 10 1990 518 521
9. MR Ujhelyi S Robert DM Cummings RD Colucci JM Sailstad PH Vlasses JW Findlay BJ Zarowitz Disposition of digoxin immune Fab in patients with kidney failure Clin Pharmacol Ther 54 1993 388 394
10. W Schaumann B Kaufmann P Neubert A Smolarz Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication Eur J Clin Pharmacol 30 1986 527 533
11. H Gault S Vasdev P Vlasses L Longerich M Dawe Interpretation of serum digoxin values in renal failure Clin Pharmacol Ther 39 1986 530 536
12. JR Hansell Effect of therapeutic digoxin antibodies on digoxin assays Arch Pathol Lab Med 113 1989 1259 1262
13. J Critchley L Critchley Digoxin toxicity in chronic renal failure: Treatment by multiple dose activated charcoal intestinal dialysis Hum Exp Toxicol 16 1997 733 735
14. C Ibanez A Carcas J Frias F Abad Activated charcoal increases digoxin elimination in patients Int J Cardiol 48 1995 27 30
15. R Lalonde R Deshpande P Hamilton W McLean D Greenway Acceleration of digoxin clearance by activated charcoal Clin Pharmacol Ther 37 1985 367 371
16. D Boldy V Smart J Vale Multiple doses of charcoal in digoxin poisoning Lancet 2 1985 1076 1077
17. G Park M Goldberg R Spector G Johnson R Feldman C Quee P Roberts The effects of activated charcoal on digoxin and digitoxin clearance Drug Intell Clin Pharm 19 1985 937 944
18. KD Lake DC Brown CD Peterson Digoxin toxicity: Enhanced systemic elimination during oral activated charcoal therapy Pharmacotherapy 4 1984 161 163
19. GL Ackerman JE Doherty W Flanigan Peritoneal dialysis and hemodialysis of tritiated digoxin Ann Intern Med 67 1967 718 729
20. O Caspi E Zylber-Katz O Gotsman DG Wolf Y Caraco Digoxin intoxication in a patient with end-stage renal disease: Efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis Ther Drug Monit 19 1997 510 515
21. E Quafie W Banner D Vernon D Christensen Failure of CAVH to remove digoxin-Fab complex in piglets Clin Toxicol 28 1990 61 68
22. K Lai R Swaminathan C Pun J Vallance-Owen Hemofiltration in digoxin overdose Arch Intern Med 146 1986 1219 1220
23. SE Warren D Fanastil Digoxin overdose. Limitations of hemoperfusion-hemodialysis treatment JAMA 242 1979 2100 2101
24. A Suzuki H Yoshida M Goto Digoxin intoxication and hemoperfusion Drug Intelligence in Clinical Pharmacology 22 1988 633 (abstr)
25. A Rowett Failure of hemoperfusion in digoxin overdose JAMA 244 1980 1558 (abstr)
26. T Risler B Grabensee Hemoperfusion in the managment of digoxin toxic reaction JAMA 242 1979 1140 (abstr)
27. T Marbury J Mahoney L Juncos R Conti R Cade Advanced digoxin toxicity in renal failure: Treatment with charcoal hemoperfusion South Med J 72 1979 279 281
28. M Tobin F Cerra J Steinbach B Mookerjee Hemoperfusion in digitalis intoxication: A comparative study of coated versus uncoated charcoal Trans Am Soc Artif Intern Organs 33 1977 730 731
29. A Carvallo B Ramirez H Honig J Knepshield G Schreiner M Gelfand Treatment of digitalis intoxication by charcoal hemoperfussion Trans Amer Soc Artif Int Organs 22 1976 718 722
30. W Hoy T Gibson T Biddle Digoxin removal in a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin Artif Organs 3 1979 124 126
31. G Gleeson J Nicotero F Duffy F Kennedy A Ticzon Resin hemoperfusion in acute digoxin intoxication JAMA 240 1978 2731 (abstr)
32. JW Smiley NM March ET Del Guercio Hemoperfusion in the management of digoxin toxicity JAMA 240 1978 2736 2737
33. H Savin L Marcus S Margel M Offarim R Mordachai Treatment of adverse digitalis effects by hemoperfusion through columns with antidigoxin antibodies bound to agarose polyacrolein microsphere beads Am Heart 113 1987 1078 1084
34. S Margel L Marcus H Savin M Offarim A Mashiah Specific removal of digoxin by hemoperfusion through agarose polyacrolein microsphere beads-antidigoxin antibodies Biomat Med Dev Artif Org 12 1984 25 36